{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:16:08Z","timestamp":1792682168430,"version":"4.5.0"},"reference-count":152,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.576622","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T08:29:27Z","timestamp":1602059367000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":381,"title":["The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens"],"prefix":"10.3389","volume":"11","author":[{"given":"Liangwei","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuna","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunwei","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.00216","article-title":"COVID-19: Emergence, Spread, Possible Treatments, and Global Burden","volume":"8","author":"Keni","year":"2020","journal-title":"Front Public Health"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01022","article-title":"Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection","volume":"11","author":"Liang","year":"2020","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","year":"2020","journal-title":"Nat Microbiol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30120-1","article-title":"An interactive web-based dashboard to track COVID-19 in real time","volume":"20","author":"Dong","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.virol.2015.03.043","article-title":"Viral membrane fusion","author":"Harrison","year":"2015","journal-title":"Virology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104792","article-title":"Coronavirus membrane fusion mechanism offers a potential target for antiviral development","volume":"178","author":"Tang","year":"2020","journal-title":"Antiviral Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat Commun"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/v4061011","article-title":"Mechanisms of coronavirus cell entry mediated by the viral spike protein","volume":"4","author":"Belouzard","year":"2012","journal-title":"Viruses"},{"key":"B11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.03.007","article-title":"SARS-CoV-2 Vaccines: Status Report","volume":"52","author":"Amanat","year":"2020","journal-title":"Immunity"},{"key":"B13","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/jmv.25726","article-title":"Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2","volume":"92","author":"Liu","year":"2020","journal-title":"J Med Virol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a013359","article-title":"N-linked protein glycosylation in the endoplasmic reticulum","volume":"5","author":"Breitling","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a013201","article-title":"Protein folding in the endoplasmic reticulum","volume":"5","author":"Braakman","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.80.3.1302-1310.2006","article-title":"Important role for the transmembrane domain of severe acute respiratory syndrome coronavirus spike protein during entry","volume":"80","author":"Broer","year":"2006","journal-title":"J Virol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.cell.2017.09.014","article-title":"SnapShot: N-Glycosylation Processing Pathways across Kingdoms","volume":"171","author":"Chung","year":"2017","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2013.04.001","article-title":"N-linked protein glycosylation in the ER","volume":"1833","author":"Aebi","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1126\/science.291.5512.2364","article-title":"Intracellular functions of N-linked glycans","volume":"291","author":"Helenius","year":"2001","journal-title":"Science"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2011.08.005","article-title":"Mechanisms and principles of N-linked protein glycosylation","volume":"21","author":"Schwarz","year":"2011","journal-title":"Curr Opin Struct Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2016.02.030","article-title":"Glycosylation Quality Control by the Golgi Structure","volume":"428","author":"Zhang","year":"2016","journal-title":"J Mol Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"Andersen","year":"2020","journal-title":"Nat Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.cell.2018.01.016","article-title":"SnapShot: O-Glycosylation Pathways across Kingdoms","volume":"172","author":"Joshi","year":"2018","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.molcel.2020.04.022","article-title":"A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells","volume":"78","author":"Hoffmann","year":"2020","journal-title":"Mol Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104742","article-title":"The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade","volume":"176","author":"Coutard","year":"2020","journal-title":"Antiviral Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e202000786","DOI":"10.26508\/lsa.202000786","article-title":"TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets","volume":"3","author":"Bestle","year":"2020","journal-title":"Life Sci Alliance"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.11.5913-5922.2004","article-title":"Intracellular targeting signals contribute to localization of coronavirus spike proteins near the virus assembly site","volume":"78","author":"Lontok","year":"2004","journal-title":"J Virol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2006.11.027","article-title":"The intracellular sites of early replication and budding of SARS-coronavirus","volume":"361","author":"Stertz","year":"2007","journal-title":"Virology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02146-06","article-title":"The cytoplasmic tail of the severe acute respiratory syndrome coronavirus spike protein contains a novel endoplasmic reticulum retrieval signal that binds COPI and promotes interaction with membrane protein","volume":"81","author":"McBride","year":"2007","journal-title":"J Virol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.000494","article-title":"The contribution of the cytoplasmic retrieval signal of severe acute respiratory syndrome coronavirus to intracellular accumulation of S proteins and incorporation of S protein into virus-like particles","volume":"97","author":"Ujike","year":"2016","journal-title":"J Gen Virol"},{"key":"B31","first-page":"3","article-title":"Properties of Coronavirus and SARS-CoV-2","volume":"42","author":"Malik","year":"2020","journal-title":"Malays J Pathol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.chom.2020.06.020","article-title":"A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition","volume":"28","author":"Dieterle","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e20201181","DOI":"10.1084\/jem.20201181","article-title":"Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses","volume":"217","author":"Schmidt","year":"2020","journal-title":"J Exp Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.77.16.8801-8811.2003","article-title":"The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex","volume":"77","author":"Bosch","year":"2003","journal-title":"J Virol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/nature13808","article-title":"Structure and immune recognition of trimeric pre-fusion HIV-1 Env","volume":"514","author":"Pancera","year":"2014","journal-title":"Nature"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nature17200","article-title":"Pre-fusion structure of a human coronavirus spike protein","volume":"531","author":"Kirchdoerfer","year":"2016","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.02.054","article-title":"Common Features of Enveloped Viruses and Implications for Immunogen Design for Next-Generation Vaccines","volume":"172","author":"Rey","year":"2018","journal-title":"Cell"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.1456","article-title":"Viral membrane fusion","volume":"15","author":"Harrison","year":"2008","journal-title":"Nat Struct Mol Biol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.16.099317","article-title":"Distinct conformational states of SARS-CoV-2 spike protein","author":"Cai","year":"2020","journal-title":"bioRxiv"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/nature16988","article-title":"Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer","volume":"531","author":"Walls","year":"2016","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/nature01188","article-title":"HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites","volume":"420","author":"Kwong","year":"2002","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/v7092856","article-title":"Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1","volume":"7","author":"Lewis","year":"2015","journal-title":"Viruses"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1126\/science.1254426","article-title":"Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions","volume":"346","author":"Munro","year":"2014","journal-title":"Science"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen","volume":"114","author":"Pallesen","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat Microbiol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"B54","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1038\/s41467-020-16048-4","article-title":"Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig","volume":"11","author":"Lei","year":"2020","journal-title":"Nat Commun"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.15.152157","article-title":"Novel ACE2-IgG1 fusions with increased activity against SARS-CoV-2","author":"Iwanaga","year":"2020","journal-title":"bioRxiv"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.19.999318","article-title":"The first-in-class peptide binder to the SARS-CoV-2 spike protein","author":"Zhang","year":"2020","journal-title":"bioRxiv"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.06.028647","article-title":"ACE2 fragment as a decoy for novel SARS-Cov-2 virus","author":"Renzi","year":"2020","journal-title":"bioRxiv"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0305-x","article-title":"Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion","volume":"30","author":"Xia","year":"2020","journal-title":"Cell Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/pro.2750","article-title":"Insights into vaccine development for acquired immune deficiency syndrome from crystal structures of human immunodeficiency virus-1 gp41 and equine infectious anemia virus gp45","volume":"24","author":"Duan","year":"2015","journal-title":"Protein Sci"},{"key":"B61","doi-asserted-by":"publisher","first-page":"eaav4580","DOI":"10.1126\/sciadv.aav4580","article-title":"A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike","volume":"5","author":"Xia","year":"2019","journal-title":"Sci Adv"},{"key":"B62","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nsmb.3293","article-title":"Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy","volume":"23","author":"Walls","year":"2016","journal-title":"Nat Struct Mol Biol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb9983","article-title":"Site-specific glycan analysis of the SARS-CoV-2 spike","volume":"369","author":"Watanabe","year":"2020","journal-title":"Science"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.eng.2020.07.014","article-title":"Mass spectrometry analysis of newly emerging coronavirus HCoV-19 spike S protein and human ACE2 reveals camouflaging glycans and unique post-translational modifications","author":"Sun","year":"2020","journal-title":"Engineering (Beijing)"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1038\/s41467-020-16567-0","article-title":"Vulnerabilities in coronavirus glycan shields despite extensive glycosylation","volume":"11","author":"Watanabe","year":"2020","journal-title":"Nat Commun"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.04.010","article-title":"Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G","volume":"165","author":"Stewart-Jones","year":"2016","journal-title":"Cell"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1803990115","article-title":"Structure of the Lassa virus glycan shield provides a model for immunological resistance","volume":"115","author":"Watanabe","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.28.013276","article-title":"Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry","author":"Zhang","year":"2020","journal-title":"bioRxiv"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1685","article-title":"Recent strategies targeting HIV glycans in vaccine design","volume":"10","author":"Horiya","year":"2014","journal-title":"Nat Chem Biol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2019.04.016","article-title":"Protein and Glycan Mimicry in HIV Vaccine Design","volume":"431","author":"Seabright","year":"2019","journal-title":"J Mol Biol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1146\/annurev-biophys-060414-034156","article-title":"Structure and Immune Recognition of the HIV Glycan Shield","volume":"47","author":"Crispin","year":"2018","journal-title":"Annu Rev Biophys"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","volume":"583","author":"Pinto","year":"2020","journal-title":"Nature"},{"key":"B73","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.immuni.2019.10.008","article-title":"Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability","volume":"51","author":"Dubrovskaya","year":"2019","journal-title":"Immunity"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01432-19","article-title":"N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies","volume":"94","author":"Huang","year":"2020","journal-title":"J Virol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2015.02.002","article-title":"Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design","volume":"11","author":"Crispin","year":"2015","journal-title":"Curr Opin Virol"},{"key":"B76","first-page":"17","article-title":"Coronaviruses\u2019 sugar shields as vaccine candidates","volume":"21","author":"Wang","year":"2020","journal-title":"Curr Trends Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15092","article-title":"Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains","volume":"8","author":"Yuan","year":"2017","journal-title":"Nat Commun"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-020-00073-5","article-title":"The COVID-19 vaccine development landscape","volume":"19","author":"Thanh Le","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102890","article-title":"Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections","volume":"58","author":"Yang","year":"2020","journal-title":"EBioMedicine"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1761267","article-title":"Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2","volume":"9","author":"Anderson","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107725","article-title":"Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections","volume":"31","author":"Lv","year":"2020","journal-title":"Cell Rep"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2020.04.009","article-title":"Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop","volume":"432","author":"Jaimes","year":"2020","journal-title":"J Mol Biol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd5223","article-title":"In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges","author":"Turonova","year":"2020","journal-title":"Science"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2090","article-title":"The spike protein of SARS-CoV\u2013a target for vaccine and therapeutic development","volume":"7","author":"Du","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3201\/1107.050219","article-title":"SARS vaccine development","volume":"11","author":"Jiang","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2020.05.004","article-title":"From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development","volume":"2","author":"Ma","year":"2020","journal-title":"Microbes Infect"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21645515.2020.1796425","article-title":"Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19","author":"Karthik","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2538-8","article-title":"A perspective on potential antibody-dependent enhancement of SARS-CoV-2","volume":"584","author":"Arvin","year":"2020","journal-title":"Nature"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2005630","article-title":"Developing Covid-19 Vaccines at Pandemic Speed","volume":"382","author":"Lurie","year":"2020","journal-title":"N Engl J Med"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.31.228486","article-title":"SARS-CoV-2 protein subunit vaccination elicits potent neutralizing antibody responses","author":"Mandolesi","year":"2020","journal-title":"BioRxiv"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40475-020-00201-6","article-title":"The SARS-CoV-2 Vaccine Pipeline: an Overview","author":"Chen","year":"2020","journal-title":"Curr Trop Med Rep"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1586\/erv.12.126","article-title":"Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome","volume":"11","author":"Jiang","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00298","article-title":"Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses","volume":"11","author":"Wang","year":"2020","journal-title":"Front Microbiol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"eabc8413","DOI":"10.1126\/sciimmunol.abc8413","article-title":"The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients","volume":"5","author":"Premkumar","year":"2020","journal-title":"Sci Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.cell.2020.06.035","article-title":"A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS","volume":"182","author":"Dai","year":"2020","journal-title":"Cell"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2020.03.007","article-title":"Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses","volume":"41","author":"Jiang","year":"2020","journal-title":"Trends Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C300520200","article-title":"A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2","volume":"279","author":"Wong","year":"2004","journal-title":"J Biol Chem"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0400-4","article-title":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine","volume":"17","author":"Tai","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M600697200","article-title":"Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody","volume":"281","author":"Prabakaran","year":"2006","journal-title":"J Biol Chem"},{"key":"B102","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/bs.aivir.2019.08.002","article-title":"Structural insights into coronavirus entry","volume":"105","author":"Tortorici","year":"2019","journal-title":"Adv Virus Res"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/nature12328","article-title":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26","volume":"500","author":"Lu","year":"2013","journal-title":"Nature"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.cell.2018.12.028","article-title":"Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion","volume":"176","author":"Walls","year":"2019","journal-title":"Cell"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.15.098079","article-title":"Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1) Formulated with Alum Induces Protective Immunity and Reduces Immune Enhancement","author":"Chen","year":"2020","journal-title":"bioRxiv"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2599-8","article-title":"A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity","author":"Yang","year":"2020","journal-title":"Nature"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","volume":"584","author":"Robbiani","year":"2020","journal-title":"Nature"},{"key":"B108","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc6952","article-title":"A potent neutralizing human antibody reveals the N-terminal domain of the Spike protein of SARS-CoV-2 as a site of vulnerability","volume":"369","author":"Chi","year":"2020","journal-title":"Science"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc5902","article-title":"Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability","volume":"369","author":"Brouwer","year":"2020","journal-title":"Science"},{"key":"B110","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41586-020-2571-7","article-title":"Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike","volume":"584","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/nature12966","article-title":"Proof of principle for epitope-focused vaccine design","volume":"507","author":"Correia","year":"2014","journal-title":"Nature"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.10.036418","article-title":"The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement","author":"Quinlan","year":"2020","journal-title":"bioRxiv"},{"key":"B113","doi-asserted-by":"publisher","first-page":"a029470","DOI":"10.1101\/cshperspect.a029470","article-title":"What Are the Most Powerful Immunogen Design Vaccine Strategies? A Structural Biologist\u2019s Perspective","volume":"9","author":"Kwong","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00738","article-title":"Structural Vaccinology for Viral Vaccine Design","volume":"10","author":"Anasir","year":"2019","journal-title":"Front Microbiol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"B116","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.antiviral.2016.11.006","article-title":"T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV","volume":"137","author":"Liu","year":"2017","journal-title":"Antiviral Res"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01781","article-title":"Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus","volume":"10","author":"Yong","year":"2019","journal-title":"Front Microbiol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.18.159202","article-title":"Divergent SARS-CoV-2-specific T and B cell responses in severe but not mild COVID-19","author":"Oja","year":"2020","journal-title":"bioRxiv"},{"key":"B119","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3390\/v12030254","article-title":"Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies","volume":"12","author":"Ahmed","year":"2020","journal-title":"Viruses"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.18.102087","article-title":"Controlling the SARS-CoV-2 Spike Glycoprotein Conformation","author":"Henderson","year":"2020","journal-title":"bioRxiv"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd0826","article-title":"Structure-based design of prefusion-stabilized SARS-CoV-2 spikes","volume":"369","author":"Hsieh","year":"2020","journal-title":"Science"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200425749","article-title":"High epitope density in a single protein molecule significantly enhances antigenicity as well as immunogenicity: a novel strategy for modern vaccine development and a preliminary investigation about B cell discrimination of monomeric proteins","volume":"35","author":"Liu","year":"2005","journal-title":"Eur J Immunol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"7712","DOI":"10.1038\/ncomms8712","article-title":"Evaluation of candidate vaccine approaches for MERS-CoV","volume":"6","author":"Wang","year":"2015","journal-title":"Nat Commun"},{"key":"B124","doi-asserted-by":"publisher","first-page":"e1001005","DOI":"10.1371\/journal.ppat.1001005","article-title":"Quasispecies theory and the behavior of RNA viruses","volume":"6","author":"Lauring","year":"2010","journal-title":"PLoS Pathog"},{"key":"B125","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.cell.2020.04.021","article-title":"Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States","volume":"181","author":"Fauver","year":"2020","journal-title":"Cell"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2014.10.008","article-title":"Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus","volume":"194","author":"Sevajol","year":"2014","journal-title":"Virus Res"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.12.148726","article-title":"The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity","author":"Zhang","year":"2020","journal-title":"bioRxiv"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.20.161323","article-title":"The D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity","author":"Hu","year":"2020","journal-title":"bioRxiv"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.04.187757","article-title":"SARS-CoV-2 Spike protein variant D614G increases infectivity and retains sensitivity to antibodies that target the receptor binding domain","author":"Yurkovetskiy","year":"2020","journal-title":"bioRxiv"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.06.040","article-title":"Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear","volume":"182","author":"Grubaugh","year":"2020","journal-title":"Cell"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.07.012","article-title":"The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity","volume":"182","author":"Li","year":"2020","journal-title":"Cell"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.22.20159905","article-title":"D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization","author":"Weissman","year":"2020","journal-title":"medRxiv"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.26.219741","article-title":"The SARS-CoV-2 Spike Variant D614G Favors an Open Conformational State","author":"Mansbach","year":"2020","journal-title":"bioRxiv"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd0831","article-title":"Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies","volume":"369","author":"Baum","year":"2020","journal-title":"Science"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd0827","article-title":"Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail","volume":"369","author":"Hansen","year":"2020","journal-title":"Science"},{"key":"B137","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.it.2020.04.008","article-title":"Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses: (Trends in Immunology 41, 355-359; 2020)","volume":"41","author":"Jiang","year":"2020","journal-title":"Trends Immunol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1093\/abt\/tbaa009","article-title":"Perspectives on the development of neutralizing antibodies against SARS-CoV-2","volume":"3","author":"Ho","year":"2020","journal-title":"Antib Ther"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb7269","article-title":"A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV","volume":"368","author":"Yuan","year":"2020","journal-title":"Science"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc5881","article-title":"Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody","volume":"369","author":"Lv","year":"2020","journal-title":"Science"},{"key":"B141","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1038\/s41467-020-16256-y","article-title":"A human monoclonal antibody blocking SARS-CoV-2 infection","volume":"11","author":"Wang","year":"2020","journal-title":"Nat Commun"},{"key":"B142","doi-asserted-by":"publisher","first-page":"e00483","DOI":"10.1128\/AAC.00483-20","article-title":"Updated Approaches against SARS-CoV-2","volume":"64","author":"Li","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.33590\/emj\/200324","article-title":"Vaccines for COVID-19: perspectives, prospects, and challenges based on candidate SARS, MERS, and animal coronavirus vaccines","author":"Saif","year":"2020","journal-title":"Euro Med J"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2019.1624482","article-title":"Antibodies and vaccines against Middle East respiratory syndrome coronavirus","volume":"8","author":"Xu","year":"2019","journal-title":"Emerg Microbes Infect"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8020309","article-title":"Vaccines against Coronaviruses: The State of the Art","volume":"8","author":"Conte","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.17.20104869","article-title":"Immunogenic profile of SARS-CoV-2 spike in individuals recovered from COVID-19","author":"Juno","year":"2020","journal-title":"medRxiv"},{"key":"B147","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1038\/s41467-020-16505-0","article-title":"Immunogenicity of a DNA vaccine candidate for COVID-19","volume":"11","author":"Smith","year":"2020","journal-title":"Nat Commun"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc6284","article-title":"DNA vaccine protection against SARS-CoV-2 in rhesus macaques","volume":"369","author":"Yu","year":"2020","journal-title":"Science"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc3539","article-title":"Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits","author":"Ravichandran","year":"2020","journal-title":"Sci Transl Med"},{"key":"B150","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/vaccines8020153","article-title":"Progress and Prospects on Vaccine Development against SARS-CoV-2","volume":"8","author":"Zhang","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"B151","doi-asserted-by":"publisher","first-page":"a030262","DOI":"10.1101\/cshperspect.a030262","article-title":"What Are the Most Powerful Immunogen Design Vaccine Strategies? Reverse Vaccinology 2.0 Shows Great Promise","volume":"9","author":"Burton","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1146\/annurev-med-121217-094234","article-title":"Structure-Based Vaccine Antigen Design","volume":"70","author":"Graham","year":"2019","journal-title":"Annu Rev Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.576622\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T08:29:32Z","timestamp":1602059372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.576622\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,7]]},"references-count":152,"alternative-id":["10.3389\/fimmu.2020.576622"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.576622","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,7]]},"article-number":"576622"}}